The Global Haemodialysis Catheters Market Size valued for USD 1,335 Million in 2021 and is anticipated to reach USD 1,934 Million by 2030 with a CAGR of 4.3% from 2022 to 2030.

Hemodialysis is a treatment used when your kidneys are damaged (Stage 5 Kidney Disease) and are no longer capable of removing extra fluid from your body and cleaning your blood. Your blood can be accessed for hemodialysis either a vascular access or hemodialysis access. Most frequently used as a temporary access, a hemodialysis catheter, also known as a central venous catheter (CVC), is also utilized in patients who have a new AV fistula but need to begin dialysis before the fistula is ready for use. The catheter is taken out once the fistula is "mature." When there are no alternative options for a permanent access, such as when a patient's blood vessels are too unhealthy for fistula development or graft insertion, a catheter may be utilized for a longer period of time.

The catheter is twice as long and roughly the width of a regular pencil. Before emerging from the skin, it will tunnel briefly beneath your skin to the front of your chest (if it enters through your neck) or front of your thigh (if it enters through your groyne). Stitches might hold the catheter's outside portion in place. A little cuff of material on the portion of the catheter that runs beneath your skin aids in the formation of scar tissue by your body. After the stitches are removed, this keeps the line in place and lowers the chance of infection.

Haemodialysis Catheters Market Dynamics

The market for haemodialysis catheters is anticipated to be driven by the rising prevalence of renal disease, high blood pressure, heart attacks, diabetes, Nephrotic syndrome, drug addiction, and autoimmune illnesses, which are some of the leading causes of kidney failure. Additionally, haemodialysis has a number of negative side effects, including anaemia, low blood pressure, muscle cramps, and sleep issues. Over the projected period, these factors are anticipated to limit the market for haemodialysis catheters.

Dialysis is required due to an increase in incidence of End-stage renal disease (ESRD), hence the number of dialysis facilities is also rising. Hemodialysis patients are treated in dialysis facilities in large numbers. Around 40,000 such facilities exist around the world, and 61% of them are owned by private or corporate entities. The remaining 31% were employed by the government or by healthcare institutions.

However, there are a number of adverse reactions to hemodialysis treatment, including itchiness, infections, anaemia, hyperkalemia, pericarditis, hypotension, hypertension, muscular cramps, and bone disorders. Hemodialysis also carries significant long-term hazards, such as insufficient waste filtration, clot formation in the dialysis graft or fistula, and the development of cardiovascular disease or cardiac arrhythmias.

As implanted ports require much less daily maintenance than tunneled catheters, the implanted sub-segment is anticipated to generate good opportunities over the projected period. As they can be used for longer than three weeks, tunneled cuffed catheters are projected to grow at a faster rate than non-cuffed tunneled catheters, which are only used in emergencies and for a shorter period of time.

Haemodialysis Catheters Market Insights

The Haemodialysis Catheters market is mainly divided into Product, Configuration, Material, end-user, and geographic segments. The Product category is divided into Non-tunneled, Cuffed tunneled. Based on Configuration, the market is Step-tip catheters (classical/standard IVF, intracytoplasmic sperm injection (ICSI)), Split-tip catheters, and others. The Material segment can be divided into Polyurethane, Silicone, 38 - 39 years, 40-42 years, 43-44 years, and over 44 years. End-user segment is further split into hospitals, Clinics/Dialysis centers, and others. Furthermore, the region segment is categorized into North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa.

Global Haemodialysis Catheters Market Geographical Competition

In 2019, Europe came in second on the global market behind North America. The areas' development is credited to established healthcare systems, rising awareness of chronic diseases, and helpful government initiatives. However, during the projection period, the Asia Pacific region is anticipated to increase at the greatest CAGR. The region is expanding as a result of favorable government policies in developing countries like China, India, and Japan as well as the rising demand for dialysis goods.

Global Haemodialysis Catheters Industry Segment Analysis

Market By Product

·         Non-tunneled

·         Cuffed tunneled

·         Non-cuffed tunneled

Market By Configuration

·         Split-tip catheters

·         Step-tip catheters

·         Symmetric catheters

Market By Material

·         Polyurethane

·         Silicone

·         38 - 39 Years

·         40-42 Years

·         43-44 Years

·         Over 44 Years

Market By End-User

·         Hospitals

·         Clinics/Dialysis centers

·         Others

Haemodialysis Catheters Market Leading Companies

The players profiled in the report are Asahi Kasei Medical Co., Ltd., Baxter International Inc., B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co. Ltd, Nipro Medical Corporation, Outset Medical, Inc, Toray Medical Co., Ltd., and Others.

Haemodialysis Catheters Market Regions